SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006888
Filing Date
2018-08-09
Accepted
2018-08-09 16:06:44
Documents
52
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20180630x10q.htm 10-Q 1235304
2 EX-31.1 glyc-20180630ex3117c6f0a.htm EX-31.1 18153
3 EX-31.2 glyc-20180630ex312b6610d.htm EX-31.2 17204
4 EX-32.1 glyc-20180630ex3211d7e53.htm EX-32.1 10257
  Complete submission text file 0001558370-18-006888.txt   4713534

Data Files

Seq Description Document Type Size
5 EX-101.INS glyc-20180630.xml EX-101.INS 1006860
6 EX-101.SCH glyc-20180630.xsd EX-101.SCH 32314
7 EX-101.CAL glyc-20180630_cal.xml EX-101.CAL 29662
8 EX-101.DEF glyc-20180630_def.xml EX-101.DEF 126797
9 EX-101.LAB glyc-20180630_lab.xml EX-101.LAB 294030
10 EX-101.PRE glyc-20180630_pre.xml EX-101.PRE 230400
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 181005047
SIC: 2834 Pharmaceutical Preparations